Ca²⁺ dysregulation in the pathogenesis of amyotrophic lateral sclerosis

Area of Science:

• Neuroscience
• Molecular Biology
• Biochemistry

Background:

• Amyotrophic Lateral Sclerosis (ALS) is a fatal neurodegenerative disease with no effective cure.
• Limited understanding of ALS molecular causes hinders pharmacotherapy development.
• Identifying dysfunctional pathways is crucial for ALS treatment.

Purpose of the Study:

• To comprehensively analyze Ca2+ homeostasis pathways implicated in ALS pathogenesis.
• To identify potential druggable targets for ALS therapy based on Ca2+ dysregulation.

Main Methods:

• Review and analysis of existing literature on Ca2+ dysregulation in ALS.
• Examination of molecular mechanisms involving plasma membrane and intracellular Ca2+ handling.
• Investigation of specific pathways such as AMPA receptor excitotoxicity, VGCCs, ER, MAMs, and lysosomal Ca2+ leak.

Main Results:

• Ca2+ dysregulation is a shared mechanism in both familial (fALS) and sporadic (sALS) forms of ALS.
• Multiple cellular mechanisms contribute to Ca2+ homeostasis disruption, including excitotoxicity and organelle dysfunction.
• Specific pathways like AMPA receptor-mediated excitotoxicity and ER/mitochondria Ca2+ handling are critically involved.

Conclusions:

• Ca2+ homeostasis disruption is a central pathological mechanism in ALS.
• Targeting specific Ca2+ pathways presents a promising strategy for developing novel ALS therapeutics.
• Further research into these pathways could lead to effective treatments for motor neuron degeneration.